Riccardo Canevari
Chief Executive Officer en RADIOPHARM THERANOSTICS LIMITED .
Fortuna: 168 249 $ al 31/03/2024
Perfil
Riccardo Canevari is currently the Chief Executive Officer, MD & Director at Radiopharm Theranostics Ltd.
He previously worked as the Senior Vice President at Novartis Oncology, Inc. and as the Chief Commercial Officer at Advanced Accelerator Applications SA.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 27/09/2022 | 4 605 789 ( 1.03% ) | 168 249 $ | 31/03/2024 |
Cargos activos de Riccardo Canevari
| Empresas | Cargo | Inicio |
|---|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Chief Executive Officer | 13/09/2021 |
Antiguos cargos conocidos de Riccardo Canevari.
| Empresas | Cargo | Fin |
|---|---|---|
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Health Services |
| Empresas privadas | 2 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
Advanced Accelerator Applications SA
 Advanced Accelerator Applications SA Medical SpecialtiesHealth Technology Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. The firm offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. It manufactures both diagnostic and therapeutic MNM products for commercialization. The company was founded by Stefano Buono in 2002 and is headquartered in Rueil-Malmaison Cedex, France. | Health Technology |
- Bolsa de valores
- Insiders
- Riccardo Canevari
